Management of postchemotherapy residual mass in patients with advanced seminoma: Indiana University experience.

PubWeight™: 1.68‹?› | Rank: Top 3%

🔗 View Article (PMID 2778480)

Published in J Clin Oncol on October 01, 1989

Authors

S M Schultz1, L H Einhorn, D J Conces, S D Williams, P J Loehrer

Author Affiliations

1: Department of Medicine, Indiana University School of Medicine, Indianapolis.

Articles citing this

A medical research council randomized trial of single agent carboplatin versus etoposide and cisplatin for advanced metastatic seminoma. MRC Testicular Tumour Working Party. Br J Cancer (2000) 1.08

The role of positron emission tomography in germ cell cancer. World J Urol (2004) 1.05

Retroperitoneal lymphadenectomy and resection for testicular cancer: an update on best practice. Ther Adv Urol (2012) 0.93

Cisplatin, vincristine and ifosphamide combination chemotherapy of metastatic seminoma: results of EORTC trial 30874. EORTC GU Group. Br J Cancer (1995) 0.80

Primary malignant mediastinal germ cell tumours: improved prognosis with platinum-based chemotherapy and surgery. Br J Cancer (1993) 0.80

Positron emission tomography (PET) in the urooncological evaluation of the small pelvis. World J Urol (2007) 0.78

Treatment of advanced seminoma with cyclophosphamide, vincristine and carboplatin on an outpatient basis. Br J Cancer (1996) 0.75

Persistent positron emission tomography-positive liver lesions after successful chemotherapy in mediastinal seminoma. J Clin Oncol (2007) 0.75

Platinum-based Chemotherapy in Primary Advanced Seminoma-a Retrospective Analysis: Treatment Results at the Northern Israel Oncology Center (1989-2010). Rambam Maimonides Med J (2014) 0.75

Positive FDG-PET/CT scans of a residual seminoma after chemotherapy and radiotherapy: case report and review of the literature. Clin Genitourin Cancer (2014) 0.75

A science for shrinking seminoma? J Clin Oncol (1990) 0.75

Secondary surgery in germ cell tumors--when and how extensively should it be performed? World J Urol (2004) 0.75

Articles by these authors

Bilateral orchiectomy with or without flutamide for metastatic prostate cancer. N Engl J Med (1998) 6.84

Guideline update for MASCC and ESMO in the prevention of chemotherapy- and radiotherapy-induced nausea and vomiting: results of the Perugia consensus conference. Ann Oncol (2010) 5.96

Phase III multicenter randomized trial of the Dartmouth regimen versus dacarbazine in patients with metastatic melanoma. J Clin Oncol (1999) 5.95

Intraperitoneal cisplatin plus intravenous cyclophosphamide versus intravenous cisplatin plus intravenous cyclophosphamide for stage III ovarian cancer. N Engl J Med (1996) 5.56

Cis-diamminedichloroplatinum, vinblastine, and bleomycin combination chemotherapy in disseminated testicular cancer. Ann Intern Med (1977) 4.91

Drugs five years later. Cisplatin. Ann Intern Med (1984) 3.69

Treatment of disseminated germ-cell tumors with cisplatin, bleomycin, and either vinblastine or etoposide. N Engl J Med (1987) 3.52

Clinical evaluation of once-weekly dosing of epoetin alfa in chemotherapy patients: improvements in hemoglobin and quality of life are similar to three-times-weekly dosing. J Clin Oncol (2001) 3.06

A randomized comparison of cisplatin alone or in combination with methotrexate, vinblastine, and doxorubicin in patients with metastatic urothelial carcinoma: a cooperative group study. J Clin Oncol (1992) 2.90

Phase III trial of gemcitabine plus cisplatin versus cisplatin alone in patients with locally advanced or metastatic non-small-cell lung cancer. J Clin Oncol (2000) 2.73

Thoracic radiotherapy does not prolong survival in patients with locally advanced, unresectable non-small cell lung cancer. Ann Intern Med (1990) 2.64

No evidence of acute cardiovascular complications of chemotherapy for testicular cancer: an analysis of the Testicular Cancer Intergroup Study. J Clin Oncol (1992) 2.11

Efficient retrovirus-mediated transfer of the multidrug resistance 1 gene into autologous human long-term repopulating hematopoietic stem cells. Nat Med (2000) 2.09

Randomized comparison of cisplatin and etoposide and either bleomycin or ifosfamide in treatment of advanced disseminated germ cell tumors: an Eastern Cooperative Oncology Group, Southwest Oncology Group, and Cancer and Leukemia Group B Study. J Clin Oncol (1998) 2.03

Comparison of the efficacy, toxicity, and pharmacokinetics of a uracil/tegafur (UFT) plus oral leucovorin (LV) regimen between Japanese and American patients with advanced colorectal cancer: joint United States and Japan study of UFT/LV. J Clin Oncol (2004) 2.02

Combination chemotherapy in disseminated testicular cancer: the Indiana University experience. Semin Oncol (1979) 1.91

Randomized study of cyclophosphamide, doxorubicin, and vincristine versus etoposide and cisplatin versus alternation of these two regimens in extensive small-cell lung cancer: a phase III trial of the Southeastern Cancer Study Group. J Clin Oncol (1992) 1.87

Late relapse of testicular cancer. J Clin Oncol (1995) 1.87

Low-coverage vaccination strategies for the conservation of endangered species. Nature (2006) 1.85

The development of non-germ cell malignancies within germ cell tumors. A clinicopathologic study of 11 cases. Cancer (1984) 1.85

A phase III randomized study comparing cisplatin and fluorouracil as single agents and in combination for advanced squamous cell carcinoma of the head and neck. J Clin Oncol (1992) 1.84

Chemotherapy of disseminated testicular cancer. A random prospective study. Cancer (1980) 1.79

High-dose chemotherapy as salvage treatment in germ cell tumors: a multivariate analysis of prognostic variables. J Clin Oncol (1996) 1.77

Gefitinib in patients with chemo-sensitive and chemo-refractory relapsed small cell cancers: a Hoosier Oncology Group phase II trial. Lung Cancer (2006) 1.77

Intrapleural therapy for malignant pleural effusions. A randomized comparison of bleomycin and tetracycline. Chest (1991) 1.72

Vinblastine plus ifosfamide plus cisplatin as initial salvage therapy in recurrent germ cell tumor. J Clin Oncol (1998) 1.72

Long-term follow-up of a phase III intergroup study of cisplatin alone or in combination with methotrexate, vinblastine, and doxorubicin in patients with metastatic urothelial carcinoma: a cooperative group study. J Clin Oncol (1997) 1.70

Decision analysis for avoiding postchemotherapy surgery in patients with disseminated nonseminomatous germ cell tumors. J Clin Oncol (1997) 1.70

Altered expression of Ape1/ref-1 in germ cell tumors and overexpression in NT2 cells confers resistance to bleomycin and radiation. Cancer Res (2001) 1.64

Hepatic resection of metastatic testicular carcinoma: a further update. Ann Surg Oncol (1999) 1.59

Thymoma: state of the art. J Clin Oncol (1999) 1.59

Superiority of nabilone over prochlorperazine as an antiemetic in patients receiving cancer chemotherapy. N Engl J Med (1979) 1.57

Cisplatin plus doxorubicin plus cyclophosphamide in metastatic or recurrent thymoma: final results of an intergroup trial. The Eastern Cooperative Oncology Group, Southwest Oncology Group, and Southeastern Cancer Study Group. J Clin Oncol (1994) 1.51

Combination chemotherapy with or without thoracic radiotherapy in limited-stage small-cell lung cancer: a randomized trial of the Southeastern Cancer Study Group. J Clin Oncol (1993) 1.51

Cisplatin-based combination chemotherapy for disseminated germ cell tumors: long-term follow-up. J Clin Oncol (1988) 1.49

Evaluation of optimal duration of chemotherapy in favorable-prognosis disseminated germ cell tumors: a Southeastern Cancer Study Group protocol. J Clin Oncol (1989) 1.46

Metastatic patterns of choroidal melanoma. Cancer (1974) 1.45

Colonic adenomas in asymptomatic women with a history of breast cancer. Am J Gastroenterol (1993) 1.44

Adjuvant bleomycin, etoposide and cisplatin in pathological stage II non-seminomatous testicular cancer. the Indiana University experience. Eur J Cancer (2000) 1.42

Hematologic malignancies associated with primary mediastinal germ-cell tumors. Ann Intern Med (1985) 1.41

Latex allergy: a threat to you and your patients? Pediatr Nurs (1993) 1.40

Significant activity of paclitaxel in advanced transitional-cell carcinoma of the urothelium: a phase II trial of the Eastern Cooperative Oncology Group. J Clin Oncol (1994) 1.39

Testicular cancer as a model for a curable neoplasm: The Richard and Hinda Rosenthal Foundation Award Lecture. Cancer Res (1981) 1.37

Improved chemotherapy in disseminated testicular cancer. J Urol (1977) 1.37

Long term effect of cis-diamminedichloride platinum (CDDP) on renal function and structure in man. Cancer (1978) 1.35

Sacrococcygeal teratoma in adults: case reports and a review of the literature. Cancer (1999) 1.33

Multisection CT: scanning techniques and clinical applications. Radiographics (2001) 1.32

Fertility after chemotherapy for testicular cancer. J Clin Oncol (1983) 1.32

Practicing with the urban underserved. A qualitative analysis of motivations, incentives, and disincentives. Arch Fam Med (1995) 1.31

Immediate adjuvant chemotherapy versus observation with treatment at relapse in pathological stage II testicular cancer. N Engl J Med (1987) 1.30

Aberrant locations and complications in initial placement of subclavian vein catheters. Arch Surg (1984) 1.29

Outcome analysis for patients with persistent nonteratomatous germ cell tumor in postchemotherapy retroperitoneal lymph node dissections. J Clin Oncol (1993) 1.29

Eastern Cooperative Oncology Group phase II trial of ifosfamide in the treatment of previously treated advanced urothelial carcinoma. J Clin Oncol (1997) 1.28

Cisplatin, doxorubicin, and cyclophosphamide plus thoracic radiation therapy for limited-stage unresectable thymoma: an intergroup trial. J Clin Oncol (1997) 1.26

Testicular cancer: the quest continues. J Natl Cancer Inst (1988) 1.25

Prognostic correlations and response to treatment in advanced metastatic malignant melanoma. Cancer Res (1974) 1.25

Germ cell tumor associated primitive neuroectodermal tumors. J Urol (2001) 1.23

Injury prevention awareness in an urban Native American population. Am J Public Health (1991) 1.22

Randomized study of cisplatin dose intensity in poor-risk germ cell tumors: a Southeastern Cancer Study Group and Southwest Oncology Group protocol. J Clin Oncol (1991) 1.22

Pulmonary histoplasmosis. Radiology (1996) 1.22

Cisplatin as first-line therapy for metastatic breast cancer. J Clin Oncol (1988) 1.22

The role of maintenance therapy in disseminated testicular cancer. N Engl J Med (1981) 1.22

Breast cancer screening in older women: practices and barriers reported by primary care physicians. J Am Geriatr Soc (1991) 1.21

Dose-intensive chemotherapy in refractory germ cell cancer--a phase I/II trial of high-dose carboplatin and etoposide with autologous bone marrow transplantation. J Clin Oncol (1989) 1.19

Late relapse of clinical stage I testicular cancer. J Urol (1995) 1.17

Understanding physicians' decisions to practice in rural areas as a basis for developing recruitment and retention strategies. J Ambul Care Mark (1994) 1.17

Importance of bleomycin in favorable-prognosis disseminated germ cell tumors: an Eastern Cooperative Oncology Group trial. J Clin Oncol (1995) 1.16

HOXB13 is downregulated in colorectal cancer to confer TCF4-mediated transactivation. Br J Cancer (2005) 1.15

High-dose carboplatin and etoposide with autologous bone marrow transplantation in refractory germ cell cancer: an Eastern Cooperative Oncology Group protocol. J Clin Oncol (1992) 1.15

Results of modern therapy for patients with mediastinal nonseminomatous germ cell tumors. Cancer (2000) 1.15

Long-term results in combined-modality treatment of small cell carcinoma of the lung. Semin Oncol (1978) 1.12

Surgical resection in disseminated testicular cancer following chemotherapeutic cytoreduction. Cancer (1981) 1.11

Klinefelter's syndrome associated with mediastinal germ cell neoplasms. J Clin Oncol (1987) 1.10